FAMICLAV

Cefuroxime & Clavulanic Acid

Antiinfective

 
 
 
 
 


Indication

Respiratory tract infections: Ear, nose and throat infections such as otitis media, sinusitis, tonsillitis and pharyngitis.


Dosage and Administration

  • Lower respiratory tract infection: Acute bronchitis, acute exacerbations of chronic bronchitis and pneumonia.
  • Skin and soft tissue infections: Furunculosis, pyoderma and impetigo.
  • Genito-urinary tract infections: Pyelonephritis, urethritis and cystitis.
  • Gonorrhoea: Acute uncomplicated gonococcal urethritis and cervicitis.
  • Early Lyme Disease and subsequent prevention of late Lyme Disease


OR AS DIRECTED BY THE PHYSICIAN.


Composition

Famiclav 250 Tablet : Each film-coated tablet contains Cefuroxime 250 mg as Cefuroxime Axetil USP and Clavulanic acid 62.50 mg as diluted Potassium Clavulanate BP.

Famiclav 500 Tablet : Each film-coated tablet contains Cefuroxime 500 mg as Cefuroxime Axetil USP and Clavulanic acid 125 mg as diluted Potassium Clavulanate BP.

Famiclav Powder for Suspension: After reconstitution, each 5 ml suspension contains Cefuroxime 125 mg as Cefuroxime Axetil USP and Clavulanic acid 31.25 mg as diluted Potassium Clavulanate BP.

 
 

Other Antiinfective Products